doi: 10.1634/theoncologist. 2018-0072 34. Hodi FS, O ’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med (2010) 363(8):711 –23. doi: 10.1056/NEJMoa1003466 35. Lu S. A Randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lungcancer - the FALUCA study. Lung Cancer (2020) 146:252 –62. doi: 10.1016/ j.lungcan.2020.06.016 36. Wang-Gillam A, Li C, Bodoky G, Dean A, Shan Y, Jameson G, et al. Nanoliposomal irinotecan with ﬂuorouracil and folinic acid in metastatic pancreatic cancer after p revious gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial. Lancet (2016) 387(10018):545 –57.